Revvity | PKI - Les Charges D'Exploitation





Les Charges D'Exploitation Changement Date
Agilent USD 1.43B 2M 2026-06
Align Technology USD 821.72M 43.15M 2026-09
Bio Techne USD 243.9M 17.7M 2026-09
Bio-Rad Laboratories USD 7.6B 429.1M 2026-09
Bruker USD 790.5M 21.6M 2026-09
Celltrion KRW 133.99B 14.77B 2026-06
Charles River Laboratories USD 3.23B 387.38M 2026-09
Cspc Pharmaceutical CNY 5.91B 512.77M 2025-12
Danaher USD 53.62B 1.04B 2026-09
Dentsply International USD 1.36B 4M 2026-09
Deva Holding AS TRY 1.35B 178.26M 2023-09
Dianthus Therapeutics USD 62.24M 15.25M 2026-06
Divis Laboratories Ltd INR 22.52B 3.01B 2026-09
Edwards Lifesciences USD 10.86B 9.64B 2026-09
Illumina USD 525M 374M 2026-09
Intuitive Surgical USD 2B 86.5M 2026-09
IQVIA Holdings USD 3.82B 2.05B 2026-09
Kangmei Pharma CNY 1.22B 130.32M 2026-06
Knight Therapeutics CAD 126.9M 8.29M 2025-12
Laboratorios Farma EUR 313.62M 17.98M 2023-12
Laboratory Of America USD 3.39B 117.6M 2026-09
Malin Corporation EUR 1.1M 400K 2024-12
Medical Developments International AUD 21.61M 11.59M 2025-12
Mesa Laboratories USD 33.98M 2.03M 2024-12
Mettler Toledo International USD 77.66M 662.11M 2026-09
Myriad Genetics USD 212.8M 16.2M 2025-12
Neuren Pharmaceuticals AUD 25.23M 16.54M 2025-12
OraSure Technologies USD 40.35M 2.45M 2025-12
Organigram Holdings CAD 100.45M 30.86M 2026-06
Ovoca Bio EUR 173K 990K 2025-12
Pacific Biosciences Of California USD 97.83M 41.29M 2025-12
Pharma Mar EUR 46.77M 4.24M 2026-09
Qiagen NV USD 393.64M 17.95M 2026-06
Quest Diagnostics USD 2.62B 34M 2026-09
Quidel USD 606.8M 39.4M 2026-09
Repligen USD 185.01M 2.01M 2026-09
Revvity USD 604.27M 719K 2026-09
Sartorius EUR 746.5M 1.3M 2026-09
Sino Biopharmaceutical CNY 12.39B 1.26B 2025-06
Thermo Fisher Scientific USD 9.68B 134M 2026-09
Tilray USD 237.52M 17.34M 2025-09
Waters USD 527M 592M 2026-06
Zealand Pharma A/S 573M 202.97M 2026-03
Zz Pientze Pharmaceu CNY 1.54B 90.74M 2026-09